Rallybio Corporation (RLYB)
NASDAQ: RLYB · IEX Real-Time Price · USD
1.200
-0.160 (-11.76%)
At close: Jul 2, 2024, 4:00 PM
1.320
+0.120 (10.00%)
After-hours: Jul 2, 2024, 7:50 PM EDT
Rallybio Stock Forecast
RLYB's stock price has decreased by -79.66% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Rallybio stock have an average target of 8.90, with a low estimate of 1.50 and a high estimate of 15. The average target predicts an increase of 641.67% from the current stock price of 1.20.
Analyst Consensus: Buy
* Price targets were last updated on May 10, 2024.
Analyst Ratings
The average analyst rating for Rallybio stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 4 | 4 | 4 | 4 | 3 | 3 |
Hold | 0 | 1 | 1 | 1 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | May 15, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +650.00% | May 10, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $8 | Buy | Reiterates | $8 | +566.67% | Apr 19, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $8 | Buy | Reiterates | $8 | +566.67% | Apr 18, 2024 |
Wedbush | Wedbush | Buy Maintains $13 → $11 | Buy | Maintains | $13 → $11 | +816.67% | Apr 11, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.44
from -1.84
EPS Next Year
-1.28
from -1.44
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | 194.7M | 649.4M |
Avg | n/a | n/a | n/a | 189.1M | 630.9M |
Low | n/a | n/a | n/a | 181.7M | 606.1M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 243.4% |
Avg | - | - | - | - | 233.6% |
Low | - | - | - | - | 220.5% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -0.98 | -0.59 | -0.45 |
Avg | -1.44 | -1.28 | -1.28 |
Low | -1.73 | -1.73 | -1.95 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.